Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Renal Cell × Surgical Procedures, Operative × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 6 Sarcoma 4 Lung Neoplasms 4 Glioblastoma 4 Stomach Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Oropharyngeal Neoplasms 3 Mouth Neoplasms 3 Breast Neoplasms 3 Sarcoma, Ewing 2 Recurrence 2 Prostatic Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Hypopharyngeal Neoplasms 2 Colorectal Neoplasms 2 Brain Neoplasms 2 Wilms Tumor 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Thymic epithelial tumor 1 Sinonasal Squamous Cell Carcinoma 1 Rectal Neoplasms 1 Pilonidal Sinus 1 Patient Preference 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Osteosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1

Interventions

pembrolizumab 27 Nivolumab 26 cabozantinib 25 Magnetic Resonance Spectroscopy 19 Specimen Handling 16 Ipilimumab 16 lenvatinib 10 belzutifan 7 atezolizumab 7 Biopsy 7 Axitinib 7 Sunitinib 6 Everolimus 6 CTLA-4 Antigen 6 avelumab 5 aldesleukin 5 Radiosurgery 5 Immunoglobulin G 5 Bevacizumab 5 pazopanib 4 fludarabine 4 Disulfides 4 Cyclophosphamide 4 zimberelimab 3 palbociclib 3 cemiplimab 3 Radiotherapy 3 Nephrectomy 3 IFL protocol 3 toripalimab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡